Margin resik: Precision BioSciences, Inc. (DTIL)

DTIL (Precision BioSciences) - tandha merek perusahaan

The net margin per ruble of revenue on this Precision BioSciences (DTIL) chart from the GURU.Markets service demonstrates market expectations, where the value of -87.50 reflects this status. This trend is driven by the bet on the ARCUS platform and an academic approach to R&D. The model is based on AI solutions without in-house production. Calibrated diagnostic systems and reserved capacities of contract manufacturing plants support stability.

Margin dodolan perusahaan precisionbiosciences.com (DTIL): kanggo periode 04.07.2022 - 19.11.2026

Ringkesan rincian data analitis Precision BioSciences, Inc. (DTIL)

- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
Analisis komprehensif perusahaan:Precision BioSciences
Barang unggulan precisionbiosciences.com

Sales margins determine the share of net profit in total revenue, capturing the final efficiency of all trading operations. This metric distinguishes sustainable operating profit from short-term market anomalies. By analyzing actual net profit margins, an investor can observe expense trends and the business's pricing power. For Precision BioSciences (DTIL), this indicator reflects the implementation costs of ARCUS AI platforms. The automation of genome bioscreening should reduce costs, thereby stabilizing profitability.

Pesaing wigati

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan resik|Benitec Biopharma - Rentabilitas dodolan miturut bathi resik|DSGN: Rentabilitas dodolan resik|RCKT: Rentabilitas dodolan miturut bathi resik|FDMT - Margin dodolan resik|LXEO: Margin dodolan resik|Korro Bio Inc. - Tingkat bathi resik|EDIT (editasmedicine.com) - Margin dodolan resik|Margin resik SLN|Margin resik ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan resik|Margin resik Sangamo SGMO|NAUT: Rentabilitas dodolan resik|MGX: Rentabilitas dodolan miturut bathi resik|GBIO - Margin dodolan resik|BOLD: Margin dodolan resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX